title: [Diabetic nephropathy: an update].
abstract: Diabetes has a constantly growing prevalence and leads to a number of complications such as diabetic nephropathy. A systematic screening and an adapted management are needed to limit the renal and also the cardiovascular complications linked to diabetic nephropathy. An adequate glycemic and tensional control and control of proteinuria are the priority in the care of diabetic nephropathy. Other aspects such as phospho-calcium balance, lipid panel or lifestyle changes are also important and therefore a multidisciplinary approach is essential. A better understanding of the physiopathology may lead to even more effective treatments in the future. We resume in this article the actual management of a patient suffering from diabetic nephropathy and the future treatment perspectives.
authors.affiliation: Service de médecine interne générale, HUG, Genève. karim.gariani@hcuge.ch
authors.forename: K
authors.initials: K
authors.lastname: Gariani
authors.forename: S
authors.initials: S
authors.lastname: de Seigneux
authors.forename: A
authors.initials: A
authors.lastname: Pechère-Bertschi
authors.forename: J
authors.initials: J
authors.lastname: Philippe
authors.forename: P-Y
authors.initials: PY
authors.lastname: Martin
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D003928:Diabetic Nephropathies / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy*; D004704:Endocrinology / Q000379:methods / Q000639:trends*; D017127:Glycation End Products, Advanced / Q000037:antagonists & inhibitors; D006801:Humans; D008954:Models, Biological; D012307:Risk Factors
chemical_list: D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D017127:Glycation End Products, Advanced